on 30 May 2023
Last Applicant/ Owned by
Asklepios BioPharmaceutical, Inc.
20 T.W. Alexander Drive, Suite 110, Research Triangle Park
North Carolina, , 27709
Serial Number
UK00003917053 filed on 30th May 2023
Registration Number
UK00003917053 registered on
25th Aug 2023
Correspondent Information
Forresters IP LLP
Port of Liverpool Building, Pier Head
Liverpool,
L3 1AF
Chemical preparations, enzymes, DNA vectors, viral vectors, rAAV vectors, and DNA extracts for the preparation of nucleic acid for scientific and research purposes; chemicals for use in the preparation and creation of DNA vectors, viral vectors, rAAV vectors, DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA vectors, rAAV vectors, DNA extracts and cassettes for scientific and industrial purposes; DNA vectors, viral vectors, rAAV vectors, and DNA extracts and cassettes for scientific and research use; DNA vectors, viral vectors, rAAV vectors, and DNA extracts for scientific and research purposes in the fields of agri-biotechnology and nanotechnology; Biological and biochemical reagents being RNA polymerase, DNA polymerase, DNA plasmid vectors, DNA vectors, viral vectors, and rAAV vectors, and RNA markers that form a gene analysis system not for medical purposes; Diagnostic reagents for scientific or research purposes, namely, a diagnostic kit consisting primarily of DNA vectors, rAAV vectors, or DNA plasmid vectors.
Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; Therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; Biotechnological products, namely, viral DNA vectors, DNA vectors, and rAAV vectors, for the delivery of genes and other materials, in the nature of DNA, RNA, or transcriptional targeting promoters, to a biological cell for medical purposes; Biological preparations, namely, viral vectors, rAAV vectors, and DNA extracts for production of DNA vectors and viral vectors for medical purposes; Recombinant viruses.
Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creating DNA extracts; scientific and technological services, namely, scientific research, analysis, design and development in the field of DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; scientific consultancy services in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology, and DNA analysis.
UK00003917053
Word
Individual